May 24, 2017
FDA Grants Priority Review Status to Ultragenyx
Read More
June 21, 2016
Takeda to Invest $65M in Ultragenyx under Rare Disease Drug Collaboration
Read More
April 26, 2015
Global Genes’ Barbara Lavery Attends XLH Network Day
Read More
November 1, 2014
Ultragenyx Granted Orphan Drug Designation for Triheptanoin for the Treatment of Glucose Transporter Type-1 Deficiency Syndrome
Read More
September 11, 2013
Startup Ultragenyx Snags PiII Program for Growing Rare-Disease Pipeline
Read More
September 13, 2011
A RARE DISEASE PATIENT PERSPECTIVE – Roy Zeighami
Read More
August 25, 2011
‘R.A.R.E.’ BOARD OF DIRECTORS AND ADVISORS ANNOUNCED
Read More
July 8, 2011
Wall Street Journal ‘Health Blog’ Reports – GETTING MORE DRUGS APPROVED FOR RARE DISEASES
Read More
July 5, 2011
A Rare Disease Pioneer Scores $45 Million for New Company – UltraGenyx
Read More
June 21, 2011
Ultragenyx – Hereditary Inclusion Body Myopathy (HIBM) New Champion for Hope
Read More
October 27, 2010
Former BioMarin exec targets orphan drugs
Read More
X